Sathya-Prasad Burjonrappa: Pediatric Trauma and Deep Venous Thrombosis
Sathya-Prasad Burjonrappa, Professor of Surgery at Rutgers Robert Wood Johnson Medical School, shared a post on LinkedIn:
“Reassessing Pediatric Trauma Deep Venous Thrombosis Incidence and Risk Factors
Sathyaprasad Burjonrappa
Introduction: Recent literature reports deep venous thrombosis (DVT) incidence in pediatric trauma patients as 0.11%.
Early transfusion, lower-extremity fracture, and prolonged immobilization increase DVT risk.
Guidelines recommend prophylactic anticoagulation in children 15 years of age or older or post-pubescent children with an Injury Severity Score greater than 25.
This study aims to reassess pediatric trauma DVT incidence and evaluate other risk factors.
Methods: Overall pediatric DVT incidence was calculated in the National Trauma Data Bank (NTDB) from 2021 to 2023, and stratified by age groups.
Potential numerical and categorical DVT risk factors were studied using logistic regressions and chi-square analyses.
Results: Pediatric trauma DVT incidence was 0.14% across 431,838 patients and stable over time (0.15% in 2021, 0.13% in 2022, and 0.14% in 2023).
Teenage incidence was highest (0.27%) compared with younger children (0.03-0.04%).
Asian (p equals .038) and White (p less than .001) race were associated with lower DVT frequency, whereas Black (p less than .001) and Pacific Islander (p equals 0.005) race, as well as male sex (p less than .001), were associated with higher frequency.
Increasing ISS (odds ratio [OR] 1.082), age (OR 1.235), BMI (OR 1.004), whole blood transfusion within 4 hours (OR 1.0004), ICU length of stay (OR 1.058), ventilator days (OR 1.033), and time to VTE prophylaxis (OR 1.106) were significantly associated with DVT.
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support